Bristol-myers Squibb Drug Patent Portfolio

Bristol-myers Squibb's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Bristol-myers Squibb News

Bristol-Myers Squibb Stock Forecast: Are Analysts Optimistic or Pessimistic? - Palmetto Grain Brokerage -

28 Jan, 2026

Is Bristol Myers Squibb (BMY) Subtly Shifting Its Narrative After Patent Expiration with Opdivo and ...

09 Jan, 2026

Ways MRK, ABBV, and BMY Might Support Investor Portfolios During a Market Decline - TipRanks.com

04 Nov, 2025

Bristol-Myers Squibb Stock Predictions: Analyst Expectations for 2027

25 Oct, 2025

See More